July 30, 2026

US bishops call for nationwide prayer and action amid rising abortion rate

NATIONAL
By OSV News, OSV News

Boxes of mifepristone under the label Mifeprex are seen April 9, 2024, at Alamo Women’s Clinic in Carbondale, Ill. In a letter posted July 27, 2026, the U.S. Conference of Catholic Bishops issued a nationwide call to prayer and action from now to the end of October, Respect Life Month, to stop the spread of abortion pills. (OSV News photo/Evelyn Hockstein, via Reuters)

WASHINGTON (OSV News) — The U.S. Catholic bishops are getting ready a nationwide call to prayer and action, with an official launch date of Aug. 18, to mobilize Catholics to address the rising abortion rate and the increased availability of an abortion-inducing drug.

“Every abortion involves the death of a child and harm to the mother. Now with easier access to abortion pills, the abortion rate is tragically climbing, along with increased health risks,” Archbishop Paul S. Coakley of Oklahoma City, president of the U. S. Conference of Catholic Bishops, and Bishop Daniel E. Thomas of Toledo, chairman of the USCCB Committee on Pro-Life Activities, said in joint remarks.

According to an estimate from Guttmacher Institute, a research firm for the abortion industry, 1.12 million abortions took place in 2025, marking a 21% increase from 2020. Guttmacher said 2020 marked “the last year of comprehensive national estimates” before the 2022 U.S. Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision. Dobbs overturned the 1973 Roe v. Wade decision and its related abortion precedents, returning the matter of abortion back to the legislative branch.

Guttmacher found the figures for 2025 were largely unchanged from the prior year, but suggested abortion numbers overall may be an undercount due to people acquiring abortion pills in advance or obtaining them by means other than U.S. abortion clinic providers.

Abortion rates in the U.S. bottomed out in 2017, when they were estimated to be just over 862,000, and began increasing again in the first Trump administration, which also approved the first generic for mifepristone, commonly called “the abortion pill,” in 2019. The pill is commonly used in combination with misoprostol for early abortion, although the same combination is also used in some miscarriage care protocols that were more recently recommended for consideration by the American College of Obstetricians and Gynecologists.

More than six of 10 abortions in the U.S. are performed through a combination of mifepristone and misoprostol, according to recent estimates.

A federal policy permitting distribution by mail of mifepristone was first issued by the Biden administration following the Dobbs decision. The policy has thus far been left in place by the second Trump administration, which approved a second generic for mifepristone in 2025 to the shock of prolife groups.

The Department of Justice, under the current Trump administration, has also sought to block state challenges to the policy pending a promised safety review by the Food and Drug Administration. But the status and timeline of the FDA review are unclear.

Archbishop Coakley and Bishop Thomas stated that the FDA “has enabled a nationwide mail-order abortion industry by allowing abortion pills to be prescribed in telehealth appointments and sold both at neighborhood pharmacies and online, circumventing state laws that protect life in the womb.”

“This leaves women vulnerable to suffering an abortion alone at home, without any medical supervision,” they said. “It also sets up additional opportunities for exploitation by violent partners or human traffickers.”

The bishops said that from the official start of the campaign through the end of October, when the Church in the U.S. marks Respect Life Month, “the USCCB Committee on Pro-Life Activities is inviting Catholics to join a focused effort of prayer and action to stop the spread of abortion pills.”

They urged Catholics to seek “the intercession of St. Joseph, Defender of Life” as well as to send messages to pharmacies and pharmaceutical companies that are involved.

The USCCB is gearing up to mobilize Catholics all over the U.S. with resources in time for the Aug. 18 launch of the campaign.

“We are setting up a simple on-line platform allowing users to click and send one message that will go to multiple entities, such as brick-and-mortar pharmacies and online pharmacies, distributors, and pharmaceutical companies,” Kat Talalas, assistant director for pro-life communications at the USCCB’s Secretariat of Pro-Life Activities, told OSV News. “We are also developing educational resources about the abortion pill, which will help explain distinctions between miscarriage care versus ending the life of a child in an abortion.”

The Catholic Church teaches that all human life is sacred from conception to natural death, and as such, opposes direct abortion. Following the Dobbs decision, U.S. Church officials have reaffirmed the Church’s concern for both mother and child, and have called for enhancing support to those made vulnerable to abortion through poverty and other factors.